An interventional study of Exercise in Fibromyalgia and Autonomic Dysfunction, sponsored by Nigde Omer Halisdemir University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-12-03.
Sponsored by Nigde Omer Halisdemir University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 195 studies in Fibromyalgia with a site in Turkey — 50 open to participants now, 54 under way, none of them phase 3. Fibromyalgia · Turkey.
Among the 195 studies in Fibromyalgia with a site in Turkey, this one is the 53rd largest by planned enrollment of the 104 interventional ones that give a count, is one of 27 that started in 2025, is one of 102 with no phase, reaches primary completion later than 35 of the 53 other live ones, and was the 151st registered.
1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.
Browse Fibromyalgia studies →50 of the 195 studies in Fibromyalgia with a site in Turkey are open now. Recruiting first, the newest first:
Karabuk University · Sites in Turkey
Ages 18–65 · Women only · Healthy volunteers
Artvin Coruh University · Sites in Turkey
Ages 18+
Artvin Coruh University · Sites in Turkey
Ages 18+
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Sites in Turkey
Ages 18–65 · Women only
Ankara Yildirim Beyazıt University · Sites in Turkey
Ages 18–65 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.
This study: 18 Years to 65 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
195 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 27 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 51 is below the median of 60 across 938 interventional studies indexed under Fibromyalgia.
Median enrollment 52 across the 104 interventional studies, 100 across the 91 observational. Of the 127 that completed or were terminated, 3 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 195 have an industry lead sponsor. The 10 most frequent:
Nigde Omer Halisdemir University is the lead sponsor of 95 studies on the registry; 32 are open to participants now.
Nigde Omer Halisdemir University has 2 studies filed under Fibromyalgia — fewer than ten, so there is no comparison to draw.
18 of the studies in Fibromyalgia with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07261696Nigde Omer Halisdemir UniversityThe Effects of Inspiratory Muscle Training Female Patients With Fibromyalgia | 2026-12-05 |
| NCT07403929Hacettepe UniversityThe Effect of Fermented Grape Juice Consumption on Fibromyalgia Patients | 2026-12-15 |
| NCT07326163Bilecik Seyh Edebali UniversitesiThe Effect of Peppermint Oil Aromatherapy on Pain, Functional Capacity and Cost in Fibromyalgia Patients | 2026-12-30 |
| NCT07878286Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyThe Role of Interoceptive Sensitivity in Central Sensitization Symptom Severity in Fibromyalgia | 2027-01-15 |
| NCT07830186Saglik Bilimleri UniversitesiQigong Intervention for Fibromyalgia | 2027-01-21 |
Add all 18 to your calendar (.ics) → With an account.
Among the 195 studies in Fibromyalgia with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and psychological symptoms. Autonomic nervous system (ANS) dysfunction, marked by increased sympathetic and reduced parasympathetic activity, is considered one of its possible mechanisms. Although exercise is recommended in treatment, low motivation and fatigue often limit participation. Therefore, inspiratory muscle training (IMT), which targets the respiratory muscles, is seen as an easy-to-apply alternative.This randomized, controlled, double-blind study will be conducted at Niğde Ömer Halisdemir University Hospital. Fifty-one women aged 18-65 years who meet the 2010/2016 ACR criteria for fibromyalgia will be randomly assigned to three groups: training (30% of maximal inspiratory pressure), sham (0-10%), and control (no training). ANS functions will be assessed using heart rate variability and the COMPASS-31 questionnaire. Pain, sleep quality, fatigue, anxiety, depression, and respiratory muscle strength will also be evaluated. Training will be performed with the Powerbreathe® device twice daily for six weeks.The study aims to investigate the effects of IMT on ANS functions in fibromyalgia and to explore its relationship with symptoms such as pain, fatigue, sleep disturbances, anxiety, and depression.
Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and psychological symptoms, the exact cause of which remains unclear. Autonomic nervous system (ANS) dysfunction, characterized by increased sympathetic activity and decreased parasympathetic tone, is considered one of the major pathophysiological mechanisms of the disease. Exercise is a strongly recommended non-pharmacological approach in the treatment of fibromyalgia; however, low motivation, fatigue, and poor adherence often limit the applicability of conventional aerobic or resistance exercise programs. Therefore, inspiratory muscle training (IMT), which specifically targets the respiratory muscles, is considered an alternative method that is easy to apply and may have regulatory effects on ANS function.
This randomized, controlled, double-blind, and prospective study will be conducted in the Rheumatology and Cardiology Clinics of Niğde Ömer Halisdemir University Training and Research Hospital. A total of 51 female participants aged 18-65 years who meet the 2010/2016 American College of Rheumatology (ACR) criteria for fibromyalgia will be randomly assigned to three groups: the training group (30% maximal inspiratory pressure [MIP]), the sham group (0-10% MIP), and the control group (no training). ANS functions will be evaluated by heart rate variability (HRV) and the COMPASS-31 questionnaire. Pain will be assessed using the Visual Analog Scale and pressure pain threshold; sleep quality by the Pittsburgh Sleep Quality Index; fatigue by the Modified Fatigue Impact Scale; anxiety and depression by the Hospital Anxiety and Depression Scale; and respiratory muscle strength by the Powerbreathe® K5 device. Training will be performed using the Powerbreathe® Classic device twice daily, seven days per week, for six weeks.
The primary aim of this study is to evaluate the effects of inspiratory muscle training on autonomic nervous system functions in patients with fibromyalgia. Secondarily, the effects of this training on symptoms such as pain, fatigue, sleep disturbances, anxiety, and depression, as well as the relationship between these symptoms and changes in ANS activity, will be investigated.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Training at 30% of maximum inspiratory pressure for 6 weeks, 2 sessions per day, 7 days a week
Other: Exercise
Training at 0-10% of maximum inspiratory pressure for 6 weeks, 2 sessions per day, 7 days a week
Other: Exercise
No Intervention
Inspiratory muscle training program will be applied to the study and sham group for 7 days/6 weeks.
Autonomic nervous system- HRV
The procedure will be performed using a 24-hour ECG Holter monitor.
Time frame: At the time participants joined the study and after the 6-week training for the intervention and sham groups, and 6 weeks later for the control group.
Autonomic Nervous System- COMPASS-31
The Composite Autonomic Symptom Score-31 questionnaire will be used.
Time frame: At the time participants joined the study and after the 6-week training for the intervention and sham groups, and 6 weeks later for the control group.
Pain- Visual Analogue Scale
Visual Analogue Scale will be used.
Time frame: At the time participants joined the study and after the 6-week training for the intervention and sham groups, and 6 weeks later for the control group.
Pain- Pressure Pain Treshold
The pain threshold will be assessed using a standard pressure algometer
Time frame: At the time participants joined the study and after the 6-week training for the intervention and sham groups, and 6 weeks later for the control group.
Sleep- Pittsburgh sleep quality index
Pittsburgh sleep quality index questionnaire will be used.
Time frame: At the time participants joined the study and after the 6-week training for the intervention and sham groups, and 6 weeks later for the control group.
Fatigue- Modified Fatigue Impact Scale
Modified Fatigue Impact Scale will be used.
Time frame: At the time participants joined the study and after the 6-week training for the intervention and sham groups, and 6 weeks later for the control group.
Anxiety and Depression- Hospital Anxiety and Depression Scale
Hospital Anxiety and Depression Scale questionnaire will be used.
Time frame: At the time participants joined the study and after the 6-week training for the intervention and sham groups, and 6 weeks later for the control group.
Maximal inspiratory pressure
Measurements will be taken using the PowerBreathe K5 MIP device to determine the exercise load.
Time frame: At the time participants joined the study and after the 6-week training for the intervention and sham groups, and 6 weeks later for the control group.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2025; primary completion for Dec 2026, 12 months later.
Of 439 non-industry interventional studies with no phase under Fibromyalgia, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 12 months is below that.
Counting every sponsor, half of 452 studies reached it within 15 months; a quarter within 6 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nigde Omer Halisdemir University